Authored by Clarion, now part of Lumanity
At the end of last year, Clarion led a panel discussion entitled, Lessons From Emerging Biopharma Companies Commercializing Their First Asset at ExL Pharma’s 3rd New Product Planning (NPP) Summit. The discussion brought together senior industry executives to share their insights and best practices in new enterprise commercialization (NEC).
The panel highlighted four key themes around preparing for successful first asset commercialization:
- Understand the Market at a Fundamental Level
- Throw out the Old Commercialization Playbook
- Start Early… Like Yesterday
- Navigate the Transition from an R&D to a Commercial Company
